News

Pharmabiz3h
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...
Shoppers 'obsessed' with £20 retinol serum that 'smooths deep wrinkles' in two months
Grounded Beauty's Egyptian Gold Retinol Face Serum combines high-strength retinol with hydrating hyaluronic acid to deliver ...
University of Surrey22h
Engineers develop breakthrough technique to enhance lifespan of next-generation fusion power plants
As the world races to build the first commercial nuclear fusion plant, engineers from the University of Surrey have made a ...
Urine test for prostate cancer offers more accurate diagnosis than blood
A urine test for prostate cancer has shown signs of being far more accurate than the blood screening currently used to track ...
FDA grants breakthrough status to Roche’s VENTANA TROP2 device
The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...